Evidence map›Paper›PMID 35346078›Full record

ArticleBMC geriatrics2022

Diabetes, sarcopenia and chronic kidney disease; the Screening for CKD among Older People across Europe (SCOPE) study.

Francesc Formiga, Rafael Moreno-González, Andrea Corsonello, Axel Carlsson, Johan Ärnlöv, Francesco Mattace-Raso, Tomasz Kostka, Christian Weingart, Regina Roller-Wirnsberger, Lisanne Tap and 9 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC geriatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 8 countries.

Francesc FormigaGeriatric Unit, Internal Medicine Department, Systemic Diseases, Ageing Group, Cardiovascular, Respiratory, Systemic Diseases, Cellular Aging Program, Institut dInvestigació Biomèdica de Bellvitge IDIBELL, Hospital Universitari de Bellvitge, LHospitalet de Llobregat, Barcelona, Spain. fformiga@bellvitgehospital.cat.
Rafael Moreno-GonzálezGeriatric Unit, Internal Medicine Department, Systemic Diseases, Ageing Group, Cardiovascular, Respiratory, Systemic Diseases, Cellular Aging Program, Institut dInvestigació Biomèdica de Bellvitge IDIBELL, Hospital Universitari de Bellvitge, LHospitalet de Llobregat, Barcelona, Spain.
Andrea CorsonelloItalian National Research Center On Aging (IRCCS INRCA), Ancona, Fermo and Cosenza, Italy.
Axel CarlssonDepartment of Neurobiology, Care Sciences and Society, Division of Family Medicine and Primary Care, Karolinska Institute, Huddinge, Sweden.
Johan ÄrnlövDepartment of Neurobiology, Care Sciences and Society, Division of Family Medicine and Primary Care, Karolinska Institute, Huddinge, Sweden.
Francesco Mattace-RasoDepartment of Internal Medicine, Section of Geriatric Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Tomasz KostkaDepartment of Geriatrics, Healthy Ageing Research Centre, Medical University of Lodz, Lodz, Poland.
Christian WeingartDepartment of Internal Medicine-Geriatrics, Institute for Biomedicine of Aging (IBA), Krankenhaus Barmherzige Brüder, Regensburg, Germany.
Regina Roller-WirnsbergerDepartment of Internal Medicine, Medical University of Graz, Graz, Austria.
Lisanne TapDepartment of Internal Medicine, Section of Geriatric Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Agnieszka GuligowskaDepartment of Geriatrics, Healthy Ageing Research Centre, Medical University of Lodz, Lodz, Poland.
Cornel SieberDepartment of Internal Medicine-Geriatrics, Institute for Biomedicine of Aging (IBA), Krankenhaus Barmherzige Brüder, Regensburg, Germany.
Gerhard WirnsbergerDepartment of Internal Medicine, Medical University of Graz, Graz, Austria.
Rada Artzi-MedvedikDepartment of Physical Therapy, Recanati School for Community Health Professions at the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-sheva, Israel.
Ilan YehoshuaMaccabi Health Organization, Negev District, Jaffa, Israel.
Cinzia GiuliItalian National Research Center On Aging (IRCCS INRCA), Ancona, Fermo and Cosenza, Italy.
Fabrizia LattanzioItalian National Research Center On Aging (IRCCS INRCA), Ancona, Fermo and Cosenza, Italy.
Xavier CorbellaGeriatric Unit, Internal Medicine Department, Systemic Diseases, Ageing Group, Cardiovascular, Respiratory, Systemic Diseases, Cellular Aging Program, Institut dInvestigació Biomèdica de Bellvitge IDIBELL, Hospital Universitari de Bellvitge, LHospitalet de Llobregat, Barcelona, Spain.
SCOPE investigators
Bellvitge University Hospital · ESIstituto Nazionale di Riposo e Cura per Anziani · ITMedical University of Lodz · PLErasmus MC · NLKrankenhaus Barmherzige Brüder · DEMedical University of Graz · ATKarolinska Institutet · SEMaccabi Healthcare Services · ILBen-Gurion University of the Negev · ILHealthcare in Sweden · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSarcopenia may be more present in older adults with diabetes (DM). Accordingly, we evaluated the prevalence of sarcopenia and its associated risk factors among community-dwelling older adults with DM.

methodsA cross-sectional analysis of older people living in the community was carried out. Participants (aged 75 years and more) came from an European multicenter prospective cohort (SCOPE study). Global geriatric assessment including short physical performance battery, handgrip strength test and bioelectrical impedance analysis was performed. Sarcopenia was defined by the updated criteria of the European Working Group on Sarcopenia in Older People (EWGSOP2). Estimated glomerular filtration rate (eGFR) was calculated using Berlin Initiative Study (BIS) to define the stages of chronic kidney disease (CKD). Previous known DM was defined as physician-diagnosed DM registered in the patient's medical record or the use of DM-related medications. Hemoglobin A1c levels and specific DM therapies administered were collected. Time elapsed from the first diagnosis of DM was not collected and, therefore, was not included in the analyses.

resultsA total of 1,420 subjects were evaluated with a median age of 79.0 (6.0) years, of which 804 (56.6%) were women and 615 (43.3%) men; 315 (22.2%) participants had prior DM diagnosis, with a median age of 80.0 (6.0), 146 (46.3%) were women. Using EWGSOP2 definition, 150 (10.6%) participants in the SCOPE study met diagnostic criteria for sarcopenia. Participants without diabetes had more often normal results in the 3 sarcopenia components than participants with diabetes [887 (80.31%) vs. 227 (72.1%), p = 0.002], highlighting higher percentages of severe sarcopenia in participants with diabetes [27 (8.6%) vs. 58 (5.2%), p = 0.028]. Confirmed or severe sarcopenia was detected in 41 (13%) participants with diabetes and 109 (9.8%) participants without diabetes (p = 0.108). According to BIS equation, sarcopenia was not significantly more prevalent in the more advanced stages of CKD (p = 0.845). In multivariate analyses, older age (odds ratios [OR], 1.17; 95% confidence interval [CI], 1.08-1.27), and lower body mass index (OR, 0.79; 95% CI, 0.71-0.89 were associated with the presence of sarcopenia.

conclusionsOne tenth of all older community-dwelling subjects have sarcopenia. Older age and being thinner, but not worse renal function, were associated with higher prevalence of sarcopenia in older older adults with diabetes.

Indexed as

Diabetes MellitusRenal Insufficiency, ChronicSarcopeniaAgedCross-Sectional StudiesFemaleHand StrengthHumansMaleProspective StudiesChronic kidney diseaseDiabetesElderlyRenal failureSarcopenia

Identifiers

PMID35346078
PMCPMC8962249
OpenAlexW4220728640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.